Hemophagocytic syndrome after Kawasaki disease

Pediatric Infectious Disease Journal

Volumn 22, Issue 7, 2003, Pages 663-666

  Palazzi, Debra L ^a   McClain, Kenneth L ^a   Kaplan, Sheldon L ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Hemophagocytic syndrome; Kawasaki disease

Indexed keywords

CYTOKINE;

ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; HEMOPHAGOCYTIC SYNDROME; HISTIOCYTE; HUMAN; IMMUNOREACTIVITY; INFECTION; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL;

ASPIRIN; CHILD; DRUG THERAPY, COMBINATION; FEMALE; HISTIOCYTOSIS, NON-LANGERHANS-CELL; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0041343210     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200307000-00021     Document Type: Article

References (30)

1. The Writing Group of the Histiocyte Society. Histiocytosis syndromes in children. Lancet 1987;1:208-9.
2. Risdall RJ, McKenna RW, Nesbit ME, et al. Virus-associated hemophagocytic syndrome, a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 1979;44:993-1002.
3. Henter JI, Elinder G, Soder O, et al. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 1991;78:2918-22.
4. Henter JI, Elinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. Semin Oncol 1991;18:29-33.
5. Arico M, Janka G, Fisher A, et al. Hemophagocytic lymphohistiocytosis: report of 122 children from the International Registry. Leukemia 1996;10:197-203.
6. Henter JI, Elinder G, Soder O, Ost A. Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis. Acta Paediatr Scand 1991;80:428-35.
7. McClain K, Gehrz R, Grierson H, et al. Virus-associated histiocytic proliferations in children: frequent association with Epstein-Barr virus and congenital or acquired immunodeficiencies. Am J Pediatr Hematol Oncol 1988;10:196-205.
8. Janka G, Imashuku S, Elinder G, et al. Infection- and malignancy-associated hemophagocytic syndromes. Hematol Oncol Clin North Am 1998;12:435-44.
9. Wong KF, Hui PK, Chan JKC, et al. The acute lupus hemophagocytic syndrome. Ann Intern Med 1991;114:387-90.
10. Al-Eid W, Al-Jefri A, Bahabri S. Hemophagocytosis complicating Kawasaki disease. Pediatr Hematol Oncol 2000;17:323-9.
11. Ohga S, Ooshima A, Fukushige J, et al. Histiocytic haemophagocytosis in a patient with Kawasaki disease: changes in the hypercytokinaemic state. Eur J Pediatr 1995;154:539-41.
12. Kaneko K, Takahashi K, Fujiwara S, et al. Kawasaki disease followed by haemophagocytic syndrome. Eur J Pediatr 1998;157:610-11.
13. Leung DYM. Clinical and immunologic aspects on Kawasaki disease. Immunodef Rev 1989;1:261-71.
14. Watson HG, Goulden NJ, Manson LM, et al. Virus-associated haemophagocytic syndrome: further evidence for a T-cell disorder. Br J Haematol 1994;86:213-5.
15. Fujiwara F, Hibi S, Imashuku S. Hypercytokinemia in hemophagocytic syndrome. Am J Pediatr Hematol Oncol 1993;15:92-8.
16. Henter J-I, Elinder G, Soder O, et al. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 1991;78:2918-22.
17. Imashuku S, Ikushima S, Esumi N, et al. Serum levels of interferon-gamma, cytotoxic factor and soluble interleukin-2 receptor in childhood hemophagocytic syndromes. Leuk Lymphoma 1991;3:287-92.
18. Komp DM, McNamara J, Buckley P. Elevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytic syndrome. Blood 1989;73:2128-32.
19. Egeler RM, Shapiro R, Loechelt B, et al. Characteristic immune abnormalities in hemophagocytic lymphohistiocytosis. J Pediatr Hematol Oncol 1996;18:340-5.
20. Palazzi DL, McClain KL, Kaplan SL. Hemophagocytic syndrome in children: an important diagnostic consideration in fever of unknown origin. Clin Infect Dis 2003;36:306-12.
21. Janka GE. Familial hemophagocytic lymphohistiocytosis. Eur J Pediatr 1983;140:221-30.
22. Chang RK. Epidemiologic characteristics of children hospitalized for Kawasaki disease in California. Pediatr Infect Dis J 2002;21:1150-5.
23. Du ZD, Zhang T, Liang L, et al. Epidemiologic picture of Kawasaki disease in Beijing from 1995 through 1999. Pediatr Infect Dis J 2002;21:103-7.
24. Royle JA, Williams K, Elliott E, et al. Kawasaki disease in Australia 1993-95. Arch Dis Child 1998;78:33-9.
25. Henter JI, Arico M, Egeler RM, et al. HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. Med Pediatr Oncol 1997;28:342-7.
26. Henter J-I, Samuelsson-Horne A, Arico M, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunotherapy and bone marrow transplantation. Blood 2002;100:2367-73.
27. Imashuku S, Hibi S, Todo S. Hemophagocytic lymphohistiocytosis in infancy and childhood. J Pediatr 1997;130:352-7.
28. Esumi N, Ikushima S, Todo S, et al. Hyperferritinemia in malignant histiocytosis, virus-associated hemophagocytic syndrome and familial erythrophagocytic lymphohistiocytosis: a survey of pediatric cases. Acta Paediatr Scand 1989;78:268-70.
29. Lim ME, Kim KS. Hemophagocytic lymphohistiocytosis. Pediatr Infect Dis J 1999;18:154-5.
30. Burns JC, Capparelli EV, Brown JA, Newburger JW, Glode MP, US/Canadian Kawasaki Syndrome Study Group. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. Pediatr Infect Dis J 1998;17:1144-8.